Evidence map›Paper›PMID 27966636›Full record

ArticleScientific reports2016

Epidemiology of two human protoparvoviruses, bufavirus and tusavirus.

Elina Väisänen, Minna Paloniemi, Inka Kuisma, Väinö Lithovius, Arun Kumar, Rauli Franssila, Kamruddin Ahmed, Eric Delwart, Timo Vesikari, Klaus Hedman and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Old and Novel Enteric Parvoviruses of Dogs.Pathogens (Basel, Switzerland) · 2023
    Review
  12. First report of canine bufavirus in India.Archives of virology · 2022
    Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Global Distribution of Human Protoparvoviruses.Emerging infectious diseases · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 4 countries.

Elina VäisänenDepartment of Virology, University of Helsinki, Helsinki 00290, Finland.
Minna PaloniemiVaccine Research Center, University of Tampere, Tampere 33520, Finland.
Inka KuismaDepartment of Virology, University of Helsinki, Helsinki 00290, Finland.
Väinö LithoviusDepartment of Virology, University of Helsinki, Helsinki 00290, Finland.
Arun KumarDepartment of Virology, University of Helsinki, Helsinki 00290, Finland.
Rauli FranssilaDepartment of Virology, University of Helsinki, Helsinki 00290, Finland.
Kamruddin AhmedDepartment of Pathobiology and Medical Diagnostics, Faculty of Medicine, Universiti Malaysia Sabah, Kota Kinabalu 88400, Sabah, Malaysia.
Eric DelwartBlood Systems Research Institute, San Francisco, CA 94118, USA.
Timo VesikariVaccine Research Center, University of Tampere, Tampere 33520, Finland.
Klaus HedmanDepartment of Virology, University of Helsinki, Helsinki 00290, Finland.
Maria Söderlund-VenermoDepartment of Virology, University of Helsinki, Helsinki 00290, Finland.
University of Helsinki · FIBlood Systems Research Institute · USHealth Sciences North · CAHelsinki University Hospital · FITampere University · FITampere University · FIUniversiti of Malaysia Sabah · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Two human parvoviruses were recently discovered by metagenomics in Africa, bufavirus (BuV) in 2012 and tusavirus (TuV) in 2014. These viruses have been studied exclusively by PCR in stool and detected only in patients with diarrhoea, although at low prevalence. Three genotypes of BuV have been identified. We detected, by in-house EIA, BuV1-3 IgG antibodies in 7/228 children (3.1%) and 10/180 adults (5.6%), whereas TuV IgG was found in one child (0.4%). All children and 91% of the adults were Finnish, yet interestingly 3/6 adults of Indian origin were BuV-IgG positive. By competition EIA, no cross-reactivity between the BuVs was detected, indicating that the BuV genotypes represent distinct serotypes. Furthermore, we analysed by BuV qPCR stool and nasal swab samples from 955 children with gastroenteritis, respiratory illness, or both, and found BuV DNA in three stools (0.3%) and for the first time in a nasal swab (0.1%). This is the first study documenting the presence of BuV and TuV antibodies in humans. Although the seroprevalences of both viruses were low in Finland, our results indicate that BuV infections might be widespread in Asia. The BuV-specific humoral immune responses appeared to be strong and long-lasting, pointing to systemic infection in humans.

Indexed as

AdultAntibodies, BacterialChild, PreschoolFecesFemaleFinlandGastroenteritisGenotypeHumansInfantMaleMiddle AgedNoseParvovirusRespiratory Tract DiseasesSeroepidemiologic StudiesAntibodies, Bacterial

Identifiers

PMID27966636
PMCPMC5155296
OpenAlexW2566243406

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.